SLC12A5 and neuropathic pain: These in-vivo findings in a neuropathic pain model lend support to our postulated mechanism of Kcc2 gene expression-enhancement by KP, specifically via nuclear action of δ-cat at the Kcc2 promoter, as we established in primary neurons and neural cells.